Harvard Bioscience (HBIO) Tops Q4 EPS by 1c
Get Alerts HBIO Hot Sheet
Price: $4.20 --0%
Revenue Growth %: -6.7%
Financial Fact:
Other income (expense), net: -67K
Today's EPS Names:
SHIM, KOD, HEWA, More
Revenue Growth %: -6.7%
Financial Fact:
Other income (expense), net: -67K
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $30.4 million versus the consensus estimate of $29.3 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- Compass Minerals (CMP) Enters Amendment to Credit Agreement
- urban-gro Inc. (UGRO) Misses Q4 EPS by 22c, offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!